Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,450 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Noninvasive Magnetic Resonance Imaging Measures of Glymphatic System Activity.
Kamagata K, Saito Y, Andica C, Uchida W, Takabayashi K, Yoshida S, Hagiwara A, Fujita S, Nakaya M, Akashi T, Wada A, Kamiya K, Hori M, Aoki S. Kamagata K, et al. Among authors: saito y. J Magn Reson Imaging. 2024 May;59(5):1476-1493. doi: 10.1002/jmri.28977. Epub 2023 Sep 1. J Magn Reson Imaging. 2024. PMID: 37655849 Review.
Current methods of preventing infectious disease and managing febrile neutropenia in childhood cancer patients: a nationwide survey in Japan.
Osone S, Shinoda K, Yamamoto N, Suzuki K, Yano M, Ishida Y, Saito Y, Sawada A, Sano H, Kato Y, Shinkoda Y, Kakazu M, Mori N, Mizutani S, Fukushima K. Osone S, et al. Among authors: saito y. Int J Clin Oncol. 2023 Feb;28(2):331-340. doi: 10.1007/s10147-022-02282-x. Epub 2022 Dec 31. Int J Clin Oncol. 2023. PMID: 36585538 Free PMC article.
Cytokine release syndrome induced by immune checkpoint inhibitor treatment for uterine cervical cancer recurrence: A case report.
Sekimata M, Kinjo Y, Tohyama A, Murakami M, Hashiwaki S, Saito Y, Higami S, Hagimoto M, Taketomi R, Hoshino K, Harada H, Ueda T, Kurita T, Matsuura Y, Yoshino K. Sekimata M, et al. Among authors: saito y. Oncol Lett. 2024 May 17;28(1):331. doi: 10.3892/ol.2024.14463. eCollection 2024 Jul. Oncol Lett. 2024. PMID: 38807673 Free PMC article.
The serum tenascin C level is a marker of metabolic disorder-related inflammation affecting pancreatic cancer prognosis.
Sato K, Hikita H, Shigekawa M, Soma K, Yamauchi R, Sung J, Kato S, Sasaki Y, Kudo S, Fukumoto K, Shirai K, Murai K, Tahata Y, Yoshioka T, Nishio A, Saito Y, Kodama T, Sasaki Y, Tatsumi T, Takehara T. Sato K, et al. Among authors: saito y. Sci Rep. 2024 May 26;14(1):12028. doi: 10.1038/s41598-024-62498-x. Sci Rep. 2024. PMID: 38797735 Free PMC article.
9,450 results